← All articles

Masseter Botox: it treats bruxism, it doesn't cure it

Toxin in the masseter reduces clenching force and relieves pain. But it doesn't treat the cause of bruxism — and ignoring that is the most common mistake with this procedure.

5 min read

Masseter Botox is probably the procedure where the line between dentistry and facial aesthetics is most visible. It started as a functional treatment and became a contouring procedure as well — and it matters which of the two you are after, because the correct approach changes.

Starting with the piece of information most often missing from this subject: toxin in the masseter does not cure bruxism.

What masseter Botox does to the muscle

The masseter is the main chewing muscle. It runs from the zygomatic arch to the angle of the jaw, and it is one of the most powerful muscles in the body relative to its size.

Anyone who clenches or grinds their teeth — by day, by night, or both — uses that muscle far beyond what chewing would require. Like any muscle under constant overload, it hypertrophies.

Botulinum toxin registered with Anvisa, the Brazilian health regulator, reduces the masseter's contraction force. Two consequences follow:

Both effects come from the same mechanism. What changes is which of them prompted the treatment.

Why it doesn't cure bruxism

This is the part almost no commercial material states clearly.

Bruxism does not originate in the muscle. The muscle is where it shows up. The causes sit elsewhere:

The toxin reduces the force with which the muscle carries out the order. It does not stop the order.

That means that, over the months, the effect fades and the picture returns if nothing else was done. And it means something more important: bruxism caused by uninvestigated sleep apnea is a health problem that keeps happening while its appearance is being treated.

The correct treatment is combined — toxin to relieve the overload, a night guard to protect the teeth, and investigation of the cause. Each one does something the others don't.

How many units of Botox in the masseter

Considerably more than in the areas of facial expression, because the muscle is large and powerful. The exact amount depends on the volume of the muscle — assessed with the patient clenching — on the degree of hypertrophy, and on the goal.

One useful characteristic: the effect in the masseter lasts longer than in most facial areas, typically five to eight months, precisely because of the higher dose and the size of the muscle.

Does the face actually slim down?

It does, and it is worth understanding the scale and the timing.

The volume loss happens through muscle disuse, not through fat removal. It is gradual: it starts to be noticeable around four to six weeks and keeps developing for two to three months.

The effect is most evident in people with real masseter hypertrophy — faces that look square in the lower third for muscular reasons. In someone with the same look from bone structure or from fat, the result is slight, because the cause is different.

That is why the assessment has to work out where the width of the lower third comes from before promising any slimming.

An aesthetic side effect to consider

Reducing masseter volume in someone who already has little support in the lower third can accentuate laxity, because you are removing volume from a structure that was helping to fill out the contour. In more mature patients, that weighs on the indication.

Risks of masseter Botox

When we advise against it

Frequently asked questions

Does Botox relieve bruxism?

It relieves the effects: it reduces clenching force, muscle pain, and the overload on teeth and joint. It does not remove the cause, which is why it is not a treatment on its own.

Why not use Botox for bruxism?

It is not that you shouldn't — it is that you shouldn't do only that. Treating the muscle alone without investigating sleep, stress and occlusion leaves the cause active and turns the procedure into indefinite maintenance.

How much does masseter Botox cost?

It depends on the number of units, which is higher than in the expression areas. The figure that matters is the annual one, given the five-to-eight-month duration.

Will I have trouble chewing?

There may be some in the first weeks, usually mild. Significant or persistent difficulty suggests more product than was needed.

Does insurance cover it?

For aesthetic purposes, no. With a documented functional indication, it is assessed case by case under the plan's rules — and it depends on a written clinical report, not on intent.

Read next